Sanofi India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2026 ,inter alia, to consider and approve the Unaudited Financial Results for the quarter and nine months ended 30th September 2026; and declare and approve Interim dividend, if any, for the financial year 2026.

19th October 2026 The Secretary, The Secretary, BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1, Block G, Dalal Street, Bandra-Kurla Complex, Bandra (E), Mumbai 400 001 Mumbai 400 051 Scrip Code: 500674 Symbol: SANOFI Sub: Meeting of the Board of Directors to be held on Thursday, 29th October 2026 Dear Sir/ Madam, Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Thursday, 29th October 2026 inter-alia to - Consider and approve the Unaudited Financial Results for the quarter and nine-months ended 30th September 2026; and - Consider, declare and approve Interim dividend, if any, for the financial year 2026. Further, in reference to our intimation dated 25th September 2026 for closure of trading window, we would also like to inform you that the trading window for the purpose of declaration of Unaudited Financial Results of the Company for the quarter and nine months ended 30th September 2026 shall remain closed from 1st October 2026 till 48 hours after the announcement of the Results to the Stock Exchanges. Kindly take the above information on record. Thanking you, Yours faithfully, For Sanofi India Limited Haresh Vala Company Secretary and Compliance Officer Membership No.: A18246 Sanofi India Limited, Sanofi House, CTS No. 117-B, L&T Business Park, Saki Vihar Road, Powai, Mumbai 400 072 - India - Tel.: +91(22) 2803 2000 - Fax: +91(22) 2803 2939 Corporate Identity Number: L24239MH1956PLC009794 Website: www.sanofiindialtd.com | www.sanofi.in Email: igrc.sil@sanofi.com